Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2238229
Max Phase: Preclinical
Molecular Formula: C26H24BrNO6
Molecular Weight: 526.38
Molecule Type: Small molecule
Associated Items:
ID: ALA2238229
Max Phase: Preclinical
Molecular Formula: C26H24BrNO6
Molecular Weight: 526.38
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(C(=O)Nc2cccc(C(=O)/C=C/c3c(OC)cc(OC)c(Br)c3OC)c2)cc1
Standard InChI: InChI=1S/C26H24BrNO6/c1-31-19-10-8-16(9-11-19)26(30)28-18-7-5-6-17(14-18)21(29)13-12-20-22(32-2)15-23(33-3)24(27)25(20)34-4/h5-15H,1-4H3,(H,28,30)/b13-12+
Standard InChI Key: IZPCLEUANGPMAP-OUKQBFOZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 526.38 | Molecular Weight (Monoisotopic): 525.0787 | AlogP: 5.63 | #Rotatable Bonds: 9 |
Polar Surface Area: 83.09 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.12 | CX LogD: 5.12 |
Aromatic Rings: 3 | Heavy Atoms: 34 | QED Weighted: 0.29 | Np Likeness Score: -0.45 |
1. Bandgar BP, Hote BS, Jalde SS, Gacche RN. (2012) Synthesis and biological evaluation of novel curcumin analogues as anti-inflammatory, anti-cancer and anti-oxidant agents, 21 (10): [10.1007/s00044-011-9834-7] |
Source(1):